ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.00%
      Bitcoin
      68,709.61
      -0.81%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. BetterLife Pharma Inc (QB) (BETRF)

      7. BetterLife Pharma Inc (QB) (BETRF) News

      BETRF

      BetterLife Pharma (QB) (BETRF)

      BetterLife Pharma Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:BETRF
      DateTimeSourceHeadlineSymbolCompany
      05/14/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      05/06/20249:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      03/05/20243:41PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      01/02/20241:37PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      12/29/20232:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      12/18/202312:13PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      11/30/20231:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      09/29/20231:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      09/28/20239:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      09/05/202310:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      07/13/202311:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      06/28/20235:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      06/28/20235:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      06/28/20235:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
      06/09/20234:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      06/06/20234:23PMEdgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:BETRFBetterLife Pharma Inc (QB)
      05/10/20239:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      04/25/20231:35PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      03/08/20232:24PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      03/07/20234:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      02/28/20239:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      01/18/20239:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      12/23/20229:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      12/08/20228:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      11/08/20225:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      09/27/20224:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      06/29/20221:22PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
      06/06/20222:35PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
      06/01/20226:00AMEdgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
      03/04/20221:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
       Showing the most relevant articles for your search:USOTC:BETRF

      Your Recent History

      EU
      XS2764264789
      ING Groep NV Bond 4000% ...
      Delayed Upgrade Clock